Diminished Rbfox1 increases vascular constriction by dynamically regulating alternative splicing of CaV1.2 calcium

Miaomiao Song1, Wei Hou1, Atta Ul Mustafa1

  • 1Key Laboratory of Cardiovascular Disease and Molecular Intervention, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China.

Insights

The RNA-binding protein Rbfox1 regulates vascular smooth muscle cell contraction by controlling CaV1.2 channel alternative splicing. Reduced Rbfox1 levels in hypertension impair this regulation, impacting blood pressure.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • RNA Biology

Background:

  • Vascular smooth muscle cell (VSMC) contraction, mediated by CaV1.2 calcium channels, is crucial for blood pressure regulation.
  • Alternative splicing (AS) of CaV1.2 channels affects their function and is implicated in cardiovascular diseases.
  • The role of RNA-binding protein Rbfox1 in vascular CaV1.2 AS and VSMC function is unknown.

Purpose of the Study:

  • To investigate the expression and function of Rbfox1 in rat vascular smooth muscle.
  • To determine if Rbfox1 regulates CaV1.2 alternative splicing in VSMCs.
  • To assess the impact of Rbfox1 on vascular constriction and CaV1.2 channel activity.

Main Methods:

  • Rbfox1 expression analysis in rat vascular smooth muscle and hypertensive models.
  • RNA-binding protein immunoprecipitation and RT-PCR to assess CaV1.2 AS.
  • Whole-cell patch clamp electrophysiology to measure CaV1.2 channel currents.
  • siRNA-mediated knockdown of Rbfox1 in VSMCs and mesenteric artery constriction assays.

Main Results:

  • Rbfox1 is expressed in rat VSMCs and its levels are decreased in hypertensive rats.
  • Rbfox1 dynamically regulates alternative splicing of CaV1.2 exons 9* and 33 in VSMCs.
  • Rbfox1 knockdown leads to hyperpolarization of the CaV1.2 current-voltage relationship.
  • Rbfox1 knockdown increases potassium-induced vasoconstriction in rat mesenteric arteries.

Conclusions:

  • Rbfox1 modulates vascular smooth muscle contraction by regulating CaV1.2 alternative splicing.
  • Decreased Rbfox1 contributes to hypertension by altering CaV1.2 channel function.
  • Rbfox1 represents a potential therapeutic target for hypertension.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
817
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
641
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.6K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
669
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
966